 |
市场调查报告书
商品编码
1863879
治疗性血浆置换市场：按类型、产品类型、疾病适应症、手术类型、最终用户和地区划分Therapeutic Plasma Exchange Market, By Type, By Product Type, By Disease Indication, By Procedure Type, By End User, By Geography |
||||||
预计到 2025 年，治疗性血浆置换市场规模将达到 14.4 亿美元，到 2032 年将达到 24.8 亿美元，2025 年至 2032 年的复合年增长率为 8.1%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2024 | 2025年市场规模： | 14.4亿美元 |
| 性能数据： | 2020年至2024年 | 预测期： | 2025年至2032年 |
| 预测期（2025-2032年）复合年增长率： | 8.10% | 2032年价值预测： | 24.8亿美元 |
全球治疗性血浆置换市场是更广泛的血液净化和分离术行业中的重要细分市场，涵盖旨在治疗各种自体免疫、神经系统疾病和血液系统疾病的先进医疗程序。
治疗性血浆置换（也称为血浆分离术）是指从患者血液中选择性地去除血浆，并同时以捐赠者血浆、白蛋白或其他血浆代用品进行替换。这种先进的治疗方法因其在治疗重症肌无力、Guillain-Barré二氏症候群、血栓性血小板低下紫斑症和各种血管炎等疾病方面的有效性而备受认可。
该市场涵盖了在医院、专科护理中心和门诊机构进行这些救生手术所需的专用医疗设备、耗材和服务。随着全球医疗系统日益认识到血浆置换疗法的治疗益处，在技术进步、临床应用拓展和患者疗效改善的推动下，该市场正经历显着增长。
市场动态
全球治疗性血浆置换市场的主要驱动力是全球自体免疫和神经系统疾病盛行率的不断上升，从而产生了对专业血浆置换疗法的巨大需求。此外，全球人口老化也是推动市场成长的重要因素，因为老年人更容易罹患需要接受治疗性血浆置换疗法的疾病。
血浆置换设备的科技进步，包括自动化和使用者友善系统的开发，正在提高该疗法的效率和安全性，并促进其在医疗机构的更广泛应用。血浆置换的临床应用范围已扩展到传统适应症之外，这正在创造新的市场机会，并且目前正在进行研究，以证明其在治疗某些精神疾病和脓毒症相关併发症等新兴疾病方面的有效性。
新兴经济体政府支持血液安全计画和医疗基础设施建设的措施也促进了市场扩张。然而，治疗性血浆置换手术的高成本限制了低收入患者和资源匮乏的医疗机构获得该服务的机会，对市场发展构成重大阻碍因素。
训练有素、能够执行复杂血浆分离术的医护人员短缺也是一项重大挑战，尤其是在发展中地区。此外，血浆衍生产品和器械核准流程的严格监管要求可能会延缓产品上市，并增加製造商的营运成本。儘管面临这些挑战，但仍存在一些机会，例如开发携带式且经济高效的血浆置换机、开拓服务不足的地区市场，以及透过临床研究和开发倡议探索新的治疗应用。
本次调查的主要特点
- 本报告对全球治疗性血浆置换市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
- 它还指出了每个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
- 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
- 该报告根据以下参数对全球治疗性血浆置换市场的主要企业进行了分析：公司概况、产品系列、主要特征、财务表现和策略。
- 本报告的研究结果将使负责人和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 本报告的目标受众是全球治疗性血浆置换市场的各个相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 相关人员可以透过各种策略矩阵轻鬆做出决策，这些矩阵用于分析全球治疗性血浆置换市场。
目录
第一章：调查目标和前提条件
- 调查目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章：市场动态、监理及趋势分析
- 市场动态
- 司机
- 抑制因素
- 机会
- 影响分析
- 重大进展
- 监管情景
- 产品发布/核准
- PEST分析
- 波特五力分析
- 併购情景
- 产业趋势
4. 全球治疗性血浆置换市场（按类型划分），2020-2032年
- 离心（间歇流和连续流）
- 薄膜过滤
5. 2020-2032年全球治疗性血浆置换市场（依产品类型划分）
- 装置
- 消耗品
- 软体和服务
6. 2020-2032年全球治疗性血浆置换市场（依疾病适应症划分）
- 神经系统疾病
- 肾臟疾病
- 血液疾病
- 代谢紊乱
- 其他迹象
7. 2020-2032年全球治疗性血浆置换市场（依手术类型划分）
- 手动TPE
- 自动化TPE
- 双重过滤血浆置换术（DFPP）
8. 2020-2032年全球治疗性血浆置换市场（依最终使用者划分）
- 医院
- 专科诊所
- 门诊手术中心
- 血液采集中心和血液成分供应商
- 输血中心
9. 2020-2032年全球治疗性血浆置换市场（按地区划分）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中非
第十章 竞争格局
- Asahi Kasei Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Haier Biomedical
- Isto Biologics
- Medica SpA
- Medicap Clinic GmbH
- Nikkiso Co., Ltd.
- SB-Kawasumi Laboratories, Inc.
- Terumo BCT, Inc.
- Zhengyuan Technology Co., Ltd.
- Grifols SA
第十一章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十二章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Therapeutic Plasma Exchange Market is estimated to be valued at USD 1.44 Bn in 2025 and is expected to reach USD 2.48 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.10% | 2032 Value Projection: | USD 2.48 Bn |
The global therapeutic plasma exchange market represents a critical segment within the broader blood purification and apheresis industry, encompassing advanced medical procedures designed to treat various autoimmune, neurological, and hematological disorders.
Therapeutic plasma exchange, also known as plasmapheresis, involves the selective removal of plasma from a patient's blood while simultaneously replacing it with donor plasma, albumin, or other plasma substitutes. This sophisticated treatment modality has gained significant recognition for its efficacy in managing conditions such as myasthenia gravis, Guillain-Barre syndrome, thrombotic thrombocytopenic purpura, and various forms of vasculitis.
The market encompasses specialized medical equipment, consumables, and services required to perform these life-saving procedures across hospitals, specialized treatment centers, and outpatient facilities. As healthcare systems worldwide increasingly recognize the therapeutic benefits of plasma exchange procedures, the market has witnessed substantial growth driven by technological advancements, expanding clinical applications, and improved patient outcomes.
Market Dynamics
The global therapeutic plasma exchange market is primarily driven by the increasing prevalence of autoimmune and neurological disorders worldwide, creating substantial demand for specialized plasma exchange procedures. The aging global population has contributed significantly to market growth, as elderly individuals are more susceptible to conditions requiring therapeutic plasma exchange interventions.
Technological advancements in apheresis equipment, including the development of automated and user-friendly systems, have enhanced procedure efficiency and safety, thereby encouraging broader adoption across healthcare facilities. The expanding clinical applications of plasma exchange therapy beyond traditional indications have opened new market opportunities, with ongoing research demonstrating efficacy in treating emerging conditions such as certain psychiatric disorders and sepsis-related complications.
Government initiatives supporting blood safety programs and healthcare infrastructure development in emerging economies have further accelerated market expansion. However, the market faces significant restraints including the high cost of therapeutic plasma exchange procedures, which limits accessibility for patients without adequate insurance coverage or in resource-constrained healthcare settings.
The shortage of trained healthcare professionals capable of performing complex apheresis procedures poses another substantial challenge, particularly in developing regions. Additionally, stringent regulatory requirements for plasma-derived products and equipment approval processes can delay market entry and increase operational costs for manufacturers. Despite these challenges, opportunities exist in the development of portable and cost-effective plasma exchange devices, expansion into underserved geographic markets, and the exploration of novel therapeutic applications through clinical research and development initiatives.
Key Features of the Study
- This report provides in-depth analysis of the global therapeutic plasma exchange market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global therapeutic plasma exchange market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include leading manufacturers and service providers in the therapeutic plasma exchange industry
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global therapeutic plasma exchange market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic plasma exchange market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Centrifugation (Intermittent and Continuous Flow Centrifugation)
- Membrane Filtration
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Devices
- Consumables
- Software and Services
- Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Neurological Disorders
- Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Myasthenia gravis
- Multiple sclerosis
- Neuromyelitis optica
- Renal Disorders
- Anti-GBM disease
- Post-renal transplant rejection
- Wegener's granulomatosis
- Hematology Disorders
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Cryoglobulinemia
- Multiple myeloma
- Metabolic Disorders
- Homozygous familial hypercholesterolemia
- Fulminant Wilson's disease
- Other Indications
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Inflammatory disorders
- Procedure Type Insights (Revenue, USD Bn, 2020 - 2032)
- Manual TPE
- Automated TPE
- Double Filtered Plasmapheresis (DFPP)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Blood Collection Centers and Blood Component Providers
- Transfusion Centers
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Asahi Kasei Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Haier Biomedical
- Isto Biologics
- Medica S.p.A.
- Medicap Clinic GmbH
- Nikkiso Co., Ltd.
- SB-Kawasumi Laboratories, Inc.
- Terumo BCT, Inc.
- Zhengyuan Technology Co., Ltd.
- Grifols S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Therapeutic Plasma Exchange Market, By Type
- Global Therapeutic Plasma Exchange Market, By Product Type
- Global Therapeutic Plasma Exchange Market, By Disease Indication
- Global Therapeutic Plasma Exchange Market, By Procedure Type
- Global Therapeutic Plasma Exchange Market, By End User
- Global Therapeutic Plasma Exchange Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Therapeutic Plasma Exchange Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Centrifugation (Intermittent and Continuous Flow Centrifugation)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Membrane Filtration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Therapeutic Plasma Exchange Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Therapeutic Plasma Exchange Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Myasthenia gravis
- Multiple sclerosis
- Neuromyelitis optica
- Renal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anti-GBM disease
- Post-renal transplant rejection
- Wegener's granulomatosis
- Hematology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Cryoglobulinemia
- Multiple myeloma
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homozygous familial hypercholesterolemia
- Fulminant Wilson's disease
- Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Inflammatory disorders
7. Global Therapeutic Plasma Exchange Market, By Procedure Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Manual TPE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Automated TPE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Double Filtered Plasmapheresis (DFPP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Therapeutic Plasma Exchange Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Collection Centers and Blood Component Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transfusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Therapeutic Plasma Exchange Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cerus Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haemonetics Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haier Biomedical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isto Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medica S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medicap Clinic GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nikkiso Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SB-Kawasumi Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo BCT, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zhengyuan Technology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
治疗性血浆置换市场：按应用、手术类型、产品类型和最终用户划分－2025-2032年全球预测
2025年全球治疗性血浆置换市场报告
治疗性血浆置换市场－全球产业规模、份额、趋势、机会和预测（按产品、技术、适应症、最终用户、地区和竞争细分，2020 年至 2030 年）
全球治疗性血浆置换市场规模（依适应症、最终用户、区域范围和预测）
全球治疗性血浆交换市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测治疗性血浆交换市场（疾病适应症：神经疾病、肾臟疾病、血液疾病、代谢障碍等）- 全球产业分析、规模、份额、数量、成长、趋势和预测，2023-2031 年